m+Medelevator.RU
← Поиск публикаций
Frontiers in cardiovascular medicine · 2022

Prognostic Value of Coronary CT Angiography-Derived Fractional Flow Reserve in Non-obstructive Coronary Artery Disease: A Prospective Multicenter Observational Study.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhou Fan, Chen Qian, Luo Xiao, Cao Wei, Li Ziwen, Zhang Bo, Schoepf U Joseph, Gill Callum E, Guo Lili, Gao Hong, Li Qingyao, Shi Yibing, Tang Tingting, Liu Xiaochen, Wu Honglin, Wang Dongqing, Xu Feng, Jin Dongsheng, Huang Sheng, Li Haige, Pan Changjie, Gu Hongmei, Xie Lixiang, Wang Ximing, Ye Jing, Jiang Jianwei, Zhao Hanqing, Fang Xiangming, Xu Yi, Xing Wei, Li Xiaohu, Yin Xindao, Lu Guang Ming, Zhang Long Jiang

Аннотация

Coronary artery disease (CAD) is a major contributor to morbidity and mortality worldwide. Myocardial ischemia may occur in patients with normal or non-obstructive CAD on invasive coronary angiography (ICA). The comprehensive evaluation of coronary CT angiography (CCTA) integrated with fractional flow reserve derived from CCTA (CT-FFR) to CAD may be essential to improve the outcomes of patients with non-obstructive CAD. China CT-FFR Study-2 (ChiCTR2000031410) is a large-scale prospective, observational study in 29 medical centers in China. The primary purpose is to uncover the relationship between the CCTA findings (including CT-FFR) and the outcome of patients with non-obstructive CAD. At least 10,000 patients with non-obstructive CAD but without previous revascularization will be enrolled. A 5-year follow-up will be performed. The primary endpoint is the occurrence of major adverse cardiovascular events (MACE), including all-cause mortality, non-fatal myocardial infarct, unplanned revascularization, and hospitalization for unstable angina. Clinical characteristics, laboratory and imaging examination results will be collected to analyze their prognostic value.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты